Risk of Slower or Declining Growth in the Generic Substitution Rate
First written in FY2017. 3 of 4 entries say "Restated". Latest entry: FY2021.
0 other companies' latest entry also says "Restated".
- FY2021RestatedAnnual report
「The growth rate of the separation of prescribing and dispensing has slowed recently, and if the rate declines in the future, it could affect the Group's results and other performance indicators.」
The risk of slowing growth and a future decline in the rate of separation of prescribing and dispensing continues. - FY2020RestatedAnnual report
「The growth rate of the separation of prescribing and dispensing has slowed recently, and if the rate declines in the future, it could affect the Group's results and other performance indicators.」
The risk of slowing growth and a future decline in the rate of separation of prescribing and dispensing continues. - FY2018RestatedAnnual report
「The growth rate of the separation of prescribing and dispensing has slowed recently, and if the rate declines in the future, it could affect the Group's results and other performance indicators.」
The risk of slowing growth and a future decline in the rate of separation of prescribing and dispensing continues to be disclosed. - FY2017First statedAnnual report
「The growth rate of the separation of prescribing and dispensing has slowed recently, and if the rate declines in the future, it could affect the Group's results and other performance indicators.」
The slowdown in the growth of, and potential future decline in, the rate of separation of prescribing and dispensing was identified as a market risk that could affect the results of the dispensing pharmacy business.